These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31435915)

  • 1. Role of Nanobiotechnology in Drug Delivery.
    Jain KK
    Methods Mol Biol; 2020; 2059():55-73. PubMed ID: 31435915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Drug Delivery Systems.
    Jain KK
    Methods Mol Biol; 2020; 2059():1-54. PubMed ID: 31435914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium nanoparticles: potential in cancer gene and drug delivery.
    Maiyo F; Singh M
    Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule delivery by nanoparticles for anticancer therapy.
    Chen ZG
    Trends Mol Med; 2010 Dec; 16(12):594-602. PubMed ID: 20846905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
    Mangraviti A; Gullotti D; Tyler B; Brem H
    J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery.
    Dhas NL; Kudarha RR; Acharya NS; Acharya SR
    Crit Rev Ther Drug Carrier Syst; 2018; 35(1):1-64. PubMed ID: 29611470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the field of nanooncology.
    Jain KK
    BMC Med; 2010 Dec; 8():83. PubMed ID: 21144040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.
    Park S; Kang S; Veach AJ; Vedvyas Y; Zarnegar R; Kim JY; Jin MM
    Biomaterials; 2010 Oct; 31(30):7766-75. PubMed ID: 20667589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nanoparticles in the improvement of systemic anticancer drug delivery.
    Field LD; Nag OK; Sangtani A; Burns KE; Delehanty JB
    Ther Deliv; 2018 Jul; 9(7):527-545. PubMed ID: 29943689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Delivery Applications of Nanoparticles in the Spine.
    Venugopal I; Mehta AI; Linninger AA
    Methods Mol Biol; 2020; 2059():121-143. PubMed ID: 31435918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design considerations for nanotherapeutics in oncology.
    Stylianopoulos T; Jain RK
    Nanomedicine; 2015 Nov; 11(8):1893-907. PubMed ID: 26282377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
    Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.
    Zamboni WC; Torchilin V; Patri AK; Hrkach J; Stern S; Lee R; Nel A; Panaro NJ; Grodzinski P
    Clin Cancer Res; 2012 Jun; 18(12):3229-41. PubMed ID: 22669131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.